Protocoled Quantitative Assessment of Aortic Regurgitation Using Videodensitometry in a Multicontinental Trial in Rotterdam, Montreal, Yamaguchi, Segeberg, Amsterdam. (ASSESS-REGURGE)
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
This observational or N/A phase trial investigates Aortic Valve Insufficiency and Aortic Valve Regurgitation and is currently completed. Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Sep 2019 — Jan 2021 [monthly]
Completed
Status: Recruiting → Completed
▶ Show 1 earlier version
-
Sep 2018 — Sep 2019 [monthly]
Recruiting
First recorded
Sep 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Erasmus Medical Center
- Imperial College London
- McGill University
- Segeberger Kliniken GmbH
- Yamaguchi University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .